Press Releases for MSFT

Press Releases
Monogram Biosciences to Present at the J.P. Morgan 27th Annual Healthcare Conference
Monogram Announces Presentation of Clinical Data for the HERmark™ Breast Cancer Assay at the CTRC-AACR San Antonio Breast Cancer Symposium
Monogram Receives Nasdaq Notification
Monogram Announces Presentations to be made at the CTRC-AACR San Antonio Breast Cancer Symposium
Monogram Biosciences Announces HER2:HER3 Heterodimer and HER3/PI3K VeraTag(TM) Assays Are Now Available for Use in Development of Cancer Therapeutics
Monogram Biosciences to Present at the Lazard Capital Markets Fifth Annual Healthcare Conference
Monogram Announces 2008 Third Quarter Financial Results
Monogram Announces a 6-to-1 Reverse Stock Split
Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
Monogram Announces Conference Call
VeraTag(TM) Assays Featured at EORTC-NCI-AACR Symposium
Wall Street Media Presents Exclusive Videos from the JMP Healthcare Focus Conference
Monogram Reaffirms Guidance for Year and Provides Update on Oncology Programs
Monogram Receives NASDAQ Notification
Monogram Biosciences to Present at the JMP Securities Healthcare Conference
Monogram and Dana-Farber Cancer Institute Initiate Evaluation of HERmark(TM) Breast Cancer Assay in Metastatic Breast Cancer
Monogram Appoints Oncologist to Board of Directors
Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc.
Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
Monogram Announces 2008 Second Quarter Financial Results
Monogram Announces Issuance of Key Patents Related to VeraTag(TM) Technology
Monogram Biosciences Announces Second Quarter 2008 Financial Results Conference Call
Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference
Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy
Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting
Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting
HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics
Monogram Announces 2008 First Quarter Financial Results
Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call
Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference
New York Medicaid Program Establishes Coverage for Trofile(TM)
Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials